1st Quarter - Report
ASCENDIS PHARMA, LLC for ASCENDIS PHARMA, LLC
Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Rare disease issues. Orphan drugs.
Foreign entity interest: Ascendis Pharma, Inc. is wholly-owned by Ascendis Pharma A/S, and its interests in relation to these issues are similar to those of Ascendis Pharma, Inc.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARY T GIBSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.